SERA PROGNOSTICS, INC. SERA
Nasdaq · XNAS · stock · Services-Medical Laboratories · website · IPO 2021-07-15
SERA PROGNOSTICS, INC. insider transactions (Form 4)
| Insider | Role | Date | Action | Shares | Price |
|---|---|---|---|---|---|
| Anderson Dyaarl Lee Jr. | Chief Commercial Officer | 2026-06-11 | Sell | 4,739 | $2.01 |
| Aerts Austin | Chief Financial Officer | 2026-06-11 | Sell | 2,037 | $2.01 |
| Lindgardt Zhenya | Chief Executive Officer | 2026-06-11 | Sell | 6,990 | $2.01 |
| Inglis Tiffany Eul Davis | Chief Medical Officer | 2026-06-11 | Sell | 362 | $2.01 |
| Jackson Benjamin | General Counsel | 2026-06-11 | Sell | 2,179 | $2.01 |
| Lindgardt Zhenya | Chief Executive Officer | 2026-06-09 | Sell | 20,755 | $2.08 |
| Aerts Austin | Chief Financial Officer | 2026-06-09 | Sell | 5,440 | $2.08 |
| Lawrence Sandra AJ | director | 2026-06-08 | Sell | 1,560 | $2.15 |
Source: SEC EDGAR filings · CIK 0001534969 · as of 2025-12-31. Facts from filings plus Stocktoria's own computed scores — not investment advice.